The role of the microbiota in the management of intensive care patients

Abstract The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly arisen from culture-independent methods based on next-ge...

Full description

Bibliographic Details
Published in:Annals of Intensive Care
Main Authors: Piotr Szychowiak, Khanh Villageois-Tran, Juliette Patrier, Jean-François Timsit, Étienne Ruppé
Format: Article
Language:English
Published: Elsevier 2022-01-01
Subjects:
Online Access:https://doi.org/10.1186/s13613-021-00976-5
_version_ 1875913193258221568
author Piotr Szychowiak
Khanh Villageois-Tran
Juliette Patrier
Jean-François Timsit
Étienne Ruppé
author_facet Piotr Szychowiak
Khanh Villageois-Tran
Juliette Patrier
Jean-François Timsit
Étienne Ruppé
author_sort Piotr Szychowiak
collection DOAJ
container_title Annals of Intensive Care
description Abstract The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly arisen from culture-independent methods based on next-generation sequencing (NGS) such as 16S profiling and shotgun metagenomics. The gut microbiota of patients hospitalized in intensive care units (ICU) undergoes many alterations because of critical illness, antibiotics, and other ICU-specific medications. It is then characterized by lower richness and diversity, and dominated by opportunistic pathogens such as Clostridioides difficile and multidrug-resistant bacteria. These alterations are associated with an increased risk of infectious complications or death. Specifically, at the time of writing, it appears possible to identify distinct microbiota patterns associated with severity or infectivity in COVID-19 patients, paving the way for the potential use of dysbiosis markers to predict patient outcomes. Correcting the microbiota disturbances to avoid their consequences is now possible. Fecal microbiota transplantation is recommended in recurrent C. difficile infections and microbiota-protecting treatments such as antibiotic inactivators are currently being developed. The growing interest in the microbiota and microbiota-associated therapies suggests that the control of the dysbiosis could be a key factor in the management of critically ill patients. The present narrative review aims to provide a synthetic overview of microbiota, from healthy individuals to critically ill patients. After an introduction to the different techniques used for studying the microbiota, we review the determinants involved in the alteration of the microbiota in ICU patients and the latter’s consequences. Last, we assess the means to prevent or correct microbiota alteration.
format Article
id doaj-art-e1d71a7cd44a4dac83ff1bc4fd30201f
institution Directory of Open Access Journals
issn 2110-5820
language English
publishDate 2022-01-01
publisher Elsevier
record_format Article
spelling doaj-art-e1d71a7cd44a4dac83ff1bc4fd30201f2026-04-03T02:09:54ZengElsevierAnnals of Intensive Care2110-58202022-01-0112111610.1186/s13613-021-00976-5The role of the microbiota in the management of intensive care patientsPiotr Szychowiak0Khanh Villageois-Tran1Juliette Patrier2Jean-François Timsit3Étienne Ruppé4Université de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMUniversité de Paris, IAME, INSERMAbstract The composition of the gut microbiota is highly dynamic and changes according to various conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence knowledge about its composition has significantly arisen from culture-independent methods based on next-generation sequencing (NGS) such as 16S profiling and shotgun metagenomics. The gut microbiota of patients hospitalized in intensive care units (ICU) undergoes many alterations because of critical illness, antibiotics, and other ICU-specific medications. It is then characterized by lower richness and diversity, and dominated by opportunistic pathogens such as Clostridioides difficile and multidrug-resistant bacteria. These alterations are associated with an increased risk of infectious complications or death. Specifically, at the time of writing, it appears possible to identify distinct microbiota patterns associated with severity or infectivity in COVID-19 patients, paving the way for the potential use of dysbiosis markers to predict patient outcomes. Correcting the microbiota disturbances to avoid their consequences is now possible. Fecal microbiota transplantation is recommended in recurrent C. difficile infections and microbiota-protecting treatments such as antibiotic inactivators are currently being developed. The growing interest in the microbiota and microbiota-associated therapies suggests that the control of the dysbiosis could be a key factor in the management of critically ill patients. The present narrative review aims to provide a synthetic overview of microbiota, from healthy individuals to critically ill patients. After an introduction to the different techniques used for studying the microbiota, we review the determinants involved in the alteration of the microbiota in ICU patients and the latter’s consequences. Last, we assess the means to prevent or correct microbiota alteration.https://doi.org/10.1186/s13613-021-00976-5MicrobiotaDysbiosisFecal microbiota transplantationProbioticsIntensive careC. difficile
spellingShingle Piotr Szychowiak
Khanh Villageois-Tran
Juliette Patrier
Jean-François Timsit
Étienne Ruppé
The role of the microbiota in the management of intensive care patients
Microbiota
Dysbiosis
Fecal microbiota transplantation
Probiotics
Intensive care
C. difficile
title The role of the microbiota in the management of intensive care patients
title_full The role of the microbiota in the management of intensive care patients
title_fullStr The role of the microbiota in the management of intensive care patients
title_full_unstemmed The role of the microbiota in the management of intensive care patients
title_short The role of the microbiota in the management of intensive care patients
title_sort role of the microbiota in the management of intensive care patients
topic Microbiota
Dysbiosis
Fecal microbiota transplantation
Probiotics
Intensive care
C. difficile
url https://doi.org/10.1186/s13613-021-00976-5
work_keys_str_mv AT piotrszychowiak theroleofthemicrobiotainthemanagementofintensivecarepatients
AT khanhvillageoistran theroleofthemicrobiotainthemanagementofintensivecarepatients
AT juliettepatrier theroleofthemicrobiotainthemanagementofintensivecarepatients
AT jeanfrancoistimsit theroleofthemicrobiotainthemanagementofintensivecarepatients
AT etienneruppe theroleofthemicrobiotainthemanagementofintensivecarepatients
AT piotrszychowiak roleofthemicrobiotainthemanagementofintensivecarepatients
AT khanhvillageoistran roleofthemicrobiotainthemanagementofintensivecarepatients
AT juliettepatrier roleofthemicrobiotainthemanagementofintensivecarepatients
AT jeanfrancoistimsit roleofthemicrobiotainthemanagementofintensivecarepatients
AT etienneruppe roleofthemicrobiotainthemanagementofintensivecarepatients